ClinicalTrials.Veeva

Menu

The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.

S

Shalvata Mental Health Center

Status

Unknown

Conditions

Attention Deficit Hyperactivity Disorder

Treatments

Drug: Methylphenidate

Study type

Interventional

Funder types

Other

Identifiers

NCT01798459
0009-12-SHA

Details and patient eligibility

About

The purpose of the study is to explore the effect of methylphenidate on state anxiety in children with attention deficit hyperactivity disorder.

Patient population: 30 children diagnosed with attention deficit hyperactivity disorder. The subjects will be of all racial, ethnical and gender categories, ranging from 8 to 18 years of age.

Structure: the study is a randomized double blind crossover study. The subjects will complete a continuous performance test, the cambridge neuropsychological test automated Battery, before and after given methylphenidate or placebo on the first day of the study. On the second day of the study, the subjects will receive either methylphenidate or placebo based on what was given on the first day of the study and they will complete the same task.

Enrollment

30 estimated patients

Sex

All

Ages

8 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Attention deficit and hyperactivity disorder
  • Children aged 8-18 years

Exclusion criteria

  • Pervasive developmental disorder
  • Schizophrenia
  • Bipolar disorder
  • Current depressive episode
  • Current Anxiety disorder
  • Drug use during the past 6 months

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

30 participants in 2 patient groups, including a placebo group

Methylphenidate
Active Comparator group
Description:
Methylphenidate 0.3 mg/kg per os is given before performing a continuous performance test.
Treatment:
Drug: Methylphenidate
Placebo
Placebo Comparator group
Description:
Placebo is given before performing a continuous performance test.

Trial contacts and locations

1

Loading...

Central trial contact

Maya Kritchman-Lupo, MD; Yuval Bloch, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems